Healios K.K. (TYO:4593)
200.00
-5.00 (-2.44%)
Nov 18, 2026, 10:20 AM JST
Healios K.K. Market Cap
Healios K.K. has a market cap or net worth of 27.11 billion as of November 17, 2026. It is the 21,148th most valuable company in the world and the 1,692nd biggest in Japan. Its market cap has decreased by 47.94% in one year.
Market Cap
27.11B
Enterprise Value
23.43B
Revenue
47.00M
Global Rank
Country Rank
#1,692 Japan
PE Ratio
n/a
ChartMarket Cap Chart
Since June 16, 2015, Healios K.K.'s market cap has decreased from 67.08B to 27.11B, a decrease of -59.58%. That is a compound annual growth rate of -7.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 27.11B | -14.30% |
| Dec 30, 2025 | 31.63B | 98.29% |
| Dec 30, 2024 | 15.95B | 29.70% |
| Dec 29, 2023 | 12.30B | -25.62% |
| Dec 30, 2022 | 16.54B | -76.63% |
| Dec 30, 2021 | 70.75B | -30.38% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Heartseed | 66.05B |
| SanBio Company | 65.73B |
| Cuorips | 58.79B |
| 3-D Matrix | 40.83B |
| Japan Tissue Engineering | 26.52B |
| Innovacell | 22.58B |
| RaQualia Pharma | 16.82B |
| CanBas | 13.94B |